Merck & Co (NY:MRK)

New York, NY – December 9, 2025 – The S&P 500 Healthcare sector found itself in a precarious position today, emerging as the biggest underperformer among its peers. While the broader S&P 500 index...

Topics Intellectual Property

Healthcare Sector Falters: S&P 500's Biggest Loser Amid Broader Market Caution

December 09, 2025

Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session.

Topics ETFs Economy Intellectual Property

Explore the top gainers and losers within the S&P500 index in today's session. ↗

December 09, 2025

Via Chartmill

Here's 1 Major Catalyst Behind Merck Stock's Recent 3.8% Bump ↗

December 09, 2025

The company is finding ways to overcome the headwinds it will encounter in the medium term.

Blockbuster drugs are a major driver of the growth of healthcare stocks.

1 Major Factor Behind the Healthcare Sector's Recent Surge ↗

December 09, 2025

With yields between 3.4% and 6.8%, you'll need to think carefully about the highest yields in the Dow before you buy them.

Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? ↗

December 07, 2025

After a long hiatus, why are the bulls so willing to buy in now?

Topics Economy Stocks

Merck's Stock is Suddenly Soaring, but Is the Struggling Healthcare Giant a Buy? ↗

December 07, 2025

These three drugmakers are all well off their recent highs. Is this a sign of opportunity or risk?

Topics Intellectual Property

Do These 3 Healthcare Stocks Need a Checkup? ↗

December 05, 2025

The healthcare stock could skyrocket if ivonescimab obtains approval from regulators, but there's still plenty of risk here.

Topics Intellectual Property

Trading Near Its 52-Week Low, Is Summit Therapeutics a Good Stock to Buy Right Now? ↗

December 05, 2025

The rebound is well underway.

Is This Pharmaceutical Giant a Buy After a Major Acquisition? ↗

December 05, 2025

These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them? ↗

Topics Death

December 05, 2025

After tepid performances throughout most of 2025, these stocks are showing some upward momentum.

With Netflix's 10-for-1 Stock Split Complete, Here Are 3 Growth Stocks to Buy in December That Could Issue Stock Splits in 2026 ↗

Topics Stocks

December 05, 2025

Surging stock prices and earnings growth potential make Meta Platforms, ASML, and Eli Lilly ripe for stock splits in the new year.

FDA Conditionally Approves Merck Animal Health's EXZOLT™ CATTLE-CA1 for the Prevention and Treatment of New World Screwworm (Cochliomyia hominivorax) Larvae (myiasis)

Topics Artificial Intelligence Economy Stocks

December 04, 2025

From Merck & Co., Inc.

These ETFs can provide me with lots of passive income.

3 Top ETFs I Plan to Pile Into in December to Boost My Passive Income in 2026 ↗

December 04, 2025

The global prescription drugs market is on the cusp of a significant expansion, with recent market reviews and forecasts projecting a robust growth trajectory through 2035. This anticipated surge,...

Topics ETFs Stocks

Global Prescription Drug Market Poised for Trillion-Dollar Surge by 2035

December 03, 2025

Wall Street has recently concluded a tumultuous yet ultimately resilient period, with the Dow Jones Industrial Average, S&P 500, and Nasdaq Composite all managing to edge higher in late November and...

Topics Artificial Intelligence Death Intellectual Property

Wall Street's Tentative Triumph: Dow, S&P 500, Nasdaq Edge Higher Amidst Shifting Tides

December 02, 2025

There's still time to get in on these rising stars.

Topics Artificial Intelligence Bonds Economy

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

Via Investor Brand Network

Topics Government

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

2 Monster Stocks in the Making to Buy and Hold ↗

December 02, 2025

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued...

1 Value Stock to Target This Week and 2 We Question

December 01, 2025

Via StockStory

Global Markets Brace as Treasury Yields Surge Amidst BOJ Speculation and Risk Aversion

December 01, 2025

As December 1, 2025, dawns, global financial markets are grappling with a significant uptick in Treasury yields, a movement primarily catalyzed by a substantial sell-off in Japanese government debt and...

Treasury Yields Surge Amid Global Shifts and Fiscal Concerns: A Deep Dive into Market Implications

Topics Bonds Economy Stocks

December 01, 2025

New York, NY – December 1, 2025 – U.S. Treasury yields have experienced a significant climb today, marking a pivotal moment for financial markets. This ascent, driven by a complex interplay of global...

Topics Bonds Credit Cards Economy

Merck Showcases Data for Alzheimer's Disease Candidates MK-2214 and MK-1167 at CTAD 2025

December 01, 2025

From Merck Sharp & Dohme

These Underrated Companies Could Be "Training-Wheels" Stocks for Long-Term Wealth Builders ↗

November 30, 2025

If you are thinking in decades and not days, this trio of dividend stocks could be the perfect starting point for your fledgling portfolio.

There are plenty of potential winners outside the world of AI.

Topics Energy Intellectual Property

3 Non-AI Stocks to Buy: MRK, UPS, CVX ↗

November 30, 2025

The struggling pharmaceutical giant is showing signs of life.

Topics Artificial Intelligence

Should You Buy This Blue Chip Pharmaceutical Stock That Just Popped 3.8%? ↗

November 29, 2025

The Dow Jones Industrial Average (DJIA) has staged a remarkable comeback, successfully erasing its November 2025 losses by the month's final trading day, Friday, November 28, 2025. This significant...

Dow Industrials Erase November Losses: A Beacon of Optimism Amidst Market Crossroads

November 28, 2025

Merck & Co. Inc. (NYSE:MRK): A Dividend Stock with Strong Profitability and Financial Health ↗

Topics Artificial Intelligence ETFs Economy

November 28, 2025

Discover Merck (MRK), a top dividend stock with a 3.58% yield, strong growth history, and excellent profitability for reliable income.

Via Chartmill

Merck to Participate in the Citi 2025 Global Healthcare Conference

November 26, 2025

From Merck & Co., Inc.

Merck to Participate in the 8th Annual Evercore ISI HealthCONx Conference

November 26, 2025

From Merck Sharp & Dohme